GO:0005175 | CD27 receptor binding | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0071987 | WD40-repeat domain binding | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0002176 | male germ cell proliferation | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0090231 | regulation of spindle checkpoint | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0044822 | poly(A) RNA binding | 2.38e-03 | 1.00e+00 | 2.611 | 4 | 25 | 799 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0007143 | female meiotic division | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0050658 | RNA transport | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0030157 | pancreatic juice secretion | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0000974 | Prp19 complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0060136 | embryonic process involved in female pregnancy | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 6 |
GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0030126 | COPI vesicle coat | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 7 |
GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 1 | 7 |
GO:0005662 | DNA replication factor A complex | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 8 |
GO:0048255 | mRNA stabilization | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0007051 | spindle organization | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0006412 | translation | 8.61e-03 | 1.00e+00 | 3.778 | 2 | 13 | 178 |
GO:0042809 | vitamin D receptor binding | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 11 |
GO:0015935 | small ribosomal subunit | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 4 | 12 |
GO:0051297 | centrosome organization | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 12 |
GO:0035371 | microtubule plus-end | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 13 |
GO:0043234 | protein complex | 1.18e-02 | 1.00e+00 | 3.539 | 2 | 8 | 210 |
GO:0005515 | protein binding | 1.21e-02 | 1.00e+00 | 1.051 | 7 | 50 | 4124 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 4 | 15 |
GO:0035145 | exon-exon junction complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 15 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 17 |
GO:0001618 | virus receptor activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 18 |
GO:0046966 | thyroid hormone receptor binding | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 20 |
GO:0001892 | embryonic placenta development | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 20 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 20 |
GO:0005761 | mitochondrial ribosome | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 20 |
GO:0003682 | chromatin binding | 1.68e-02 | 1.00e+00 | 3.276 | 2 | 3 | 252 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 21 |
GO:0034605 | cellular response to heat | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 22 |
GO:0040018 | positive regulation of multicellular organism growth | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 22 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 24 |
GO:0051219 | phosphoprotein binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 3 | 25 |
GO:0016592 | mediator complex | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 25 |
GO:0097191 | extrinsic apoptotic signaling pathway | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 30 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 30 |
GO:0003712 | transcription cofactor activity | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 3 | 35 |
GO:0003743 | translation initiation factor activity | 2.99e-02 | 1.00e+00 | 5.044 | 1 | 5 | 37 |
GO:0006952 | defense response | 2.99e-02 | 1.00e+00 | 5.044 | 1 | 1 | 37 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 1 | 39 |
GO:0097193 | intrinsic apoptotic signaling pathway | 3.95e-02 | 1.00e+00 | 4.639 | 1 | 1 | 49 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 4.03e-02 | 1.00e+00 | 4.610 | 1 | 1 | 50 |
GO:0008584 | male gonad development | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 1 | 57 |
GO:0005179 | hormone activity | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 4.89e-02 | 1.00e+00 | 4.323 | 1 | 1 | 61 |
GO:0000922 | spindle pole | 5.44e-02 | 1.00e+00 | 4.166 | 1 | 3 | 68 |
GO:0015630 | microtubule cytoskeleton | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 2 | 75 |
GO:0016020 | membrane | 6.54e-02 | 1.00e+00 | 1.601 | 3 | 25 | 1207 |
GO:0005730 | nucleolus | 6.68e-02 | 1.00e+00 | 1.589 | 3 | 21 | 1217 |
GO:0006886 | intracellular protein transport | 7.07e-02 | 1.00e+00 | 3.778 | 1 | 1 | 89 |
GO:0061024 | membrane organization | 7.07e-02 | 1.00e+00 | 3.778 | 1 | 3 | 89 |
GO:0032496 | response to lipopolysaccharide | 7.37e-02 | 1.00e+00 | 3.714 | 1 | 1 | 93 |
GO:0000086 | G2/M transition of mitotic cell cycle | 7.68e-02 | 1.00e+00 | 3.653 | 1 | 3 | 97 |
GO:0009615 | response to virus | 7.68e-02 | 1.00e+00 | 3.653 | 1 | 2 | 97 |
GO:0006413 | translational initiation | 7.83e-02 | 1.00e+00 | 3.624 | 1 | 12 | 99 |
GO:0005198 | structural molecule activity | 7.98e-02 | 1.00e+00 | 3.595 | 1 | 1 | 101 |
GO:0003735 | structural constituent of ribosome | 8.59e-02 | 1.00e+00 | 3.485 | 1 | 8 | 109 |
GO:0006397 | mRNA processing | 8.67e-02 | 1.00e+00 | 3.472 | 1 | 2 | 110 |
GO:0004872 | receptor activity | 9.12e-02 | 1.00e+00 | 3.395 | 1 | 1 | 116 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 9.33e-02 | 1.00e+00 | 1.922 | 2 | 8 | 644 |
GO:0016607 | nuclear speck | 9.57e-02 | 1.00e+00 | 3.323 | 1 | 2 | 122 |
GO:0000398 | mRNA splicing, via spliceosome | 1.00e-01 | 1.00e+00 | 3.253 | 1 | 2 | 128 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.11e-01 | 1.00e+00 | 3.104 | 1 | 4 | 142 |
GO:0001701 | in utero embryonic development | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 2 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.25e-01 | 1.00e+00 | 2.922 | 1 | 3 | 161 |
GO:0007067 | mitotic nuclear division | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 5 | 165 |
GO:0008380 | RNA splicing | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 4 | 165 |
GO:0007283 | spermatogenesis | 1.30e-01 | 1.00e+00 | 2.861 | 1 | 2 | 168 |
GO:0003713 | transcription coactivator activity | 1.41e-01 | 1.00e+00 | 2.730 | 1 | 3 | 184 |
GO:0005737 | cytoplasm | 1.43e-01 | 1.00e+00 | 0.891 | 4 | 39 | 2633 |
GO:0005813 | centrosome | 1.65e-01 | 1.00e+00 | 2.492 | 1 | 6 | 217 |
GO:0005829 | cytosol | 1.67e-01 | 1.00e+00 | 1.035 | 3 | 33 | 1787 |
GO:0046872 | metal ion binding | 1.74e-01 | 1.00e+00 | 1.386 | 2 | 10 | 934 |
GO:0003723 | RNA binding | 1.85e-01 | 1.00e+00 | 2.305 | 1 | 6 | 247 |
GO:0008285 | negative regulation of cell proliferation | 2.06e-01 | 1.00e+00 | 2.140 | 1 | 3 | 277 |
GO:0006351 | transcription, DNA-templated | 2.18e-01 | 1.00e+00 | 1.182 | 2 | 15 | 1076 |
GO:0006468 | protein phosphorylation | 2.22e-01 | 1.00e+00 | 2.020 | 1 | 3 | 301 |
GO:0000278 | mitotic cell cycle | 2.30e-01 | 1.00e+00 | 1.959 | 1 | 9 | 314 |
GO:0044267 | cellular protein metabolic process | 2.55e-01 | 1.00e+00 | 1.794 | 1 | 13 | 352 |
GO:0005634 | nucleus | 2.57e-01 | 1.00e+00 | 0.589 | 4 | 40 | 3246 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.70e-01 | 1.00e+00 | 1.695 | 1 | 6 | 377 |
GO:0016032 | viral process | 3.01e-01 | 1.00e+00 | 1.512 | 1 | 13 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.18e-01 | 1.00e+00 | 1.421 | 1 | 6 | 456 |
GO:0010467 | gene expression | 3.63e-01 | 1.00e+00 | 1.190 | 1 | 17 | 535 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.88e-01 | 1.00e+00 | 1.069 | 1 | 9 | 582 |
GO:0070062 | extracellular vesicular exosome | 4.00e-01 | 1.00e+00 | 0.573 | 2 | 28 | 1641 |
GO:0005615 | extracellular space | 4.24e-01 | 1.00e+00 | 0.907 | 1 | 2 | 651 |
GO:0005739 | mitochondrion | 4.28e-01 | 1.00e+00 | 0.889 | 1 | 4 | 659 |
GO:0006355 | regulation of transcription, DNA-templated | 4.56e-01 | 1.00e+00 | 0.772 | 1 | 9 | 715 |
GO:0008270 | zinc ion binding | 4.62e-01 | 1.00e+00 | 0.748 | 1 | 5 | 727 |
GO:0005654 | nucleoplasm | 5.29e-01 | 1.00e+00 | 0.479 | 1 | 16 | 876 |
GO:0005524 | ATP binding | 5.35e-01 | 1.00e+00 | 0.453 | 1 | 10 | 892 |
GO:0003677 | DNA binding | 5.58e-01 | 1.00e+00 | 0.366 | 1 | 12 | 947 |